Pure Global
NCT01612598

Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials

Feasibility of a Palliative Care Intervention for Patients on Phase 1 Clinical Trials
City of Hope Medical Center·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Unspecified Adult Solid Tumor, Protocol Specific
Drug/Device/Intervention
counseling intervention
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
City of Hope Medical Center
Location
Duarte,Baltimore, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2012
End date
Jan 01, 2014
Enrollment
16 participants
Primary outcome

Study accrual and retention,Change in psychological distress assessed using Distress Thermometer,Change in satisfaction with communication assessed using Satisfaction with Communication Tool,Change in QOL using Functional Assessment of Cancer Therapy- General (FACT-G) and Functional Assessment of Chronic Illness Therapy- Spirituality (FACT-Sp-12),Change in symptom intensity and distress using Memorial Symptom Assessment Scale (MSAS)

Summary

Patients enrolled in phase I clinical trials could potentially benefit from palliative care
 concurrently, yet limited evidence is available to support such a change in care. The primary
 purpose of this study is to test the feasibility of a palliative care intervention (PCI) for
 patients participating in a phase I therapeutic clinical trial

ICD-10 classifications
Carcinoma in situ, unspecifiedMalignant neoplasm, without specification of siteMalignant neoplasm, primary site unspecifiedCarcinoma in situ of other and unspecified genital organsMalignant neoplasm: Connective and soft tissue, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01612598
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01612598 through Pure Global AI's free database. This phase not specified trial is sponsored by City of Hope Medical Center and is currently Completed. The study focuses on Unspecified Adult Solid Tumor, Protocol Specific. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.